Panaji, October 18, 2024: HCG, one of India’s largest cancer care networks, is proud to announce the launch of outpatient (OPD) consultations in Goa, making specialized cancer treatment more accessible to local patients. In collaboration with local hospitals, leading oncologists such as Dr. Raghunath SK, Senior Consultant in Uro-Oncology, and Dr. Natraj, Senior Consultant Hematology and BMT from HCG Cancer Centre Bangalore, will conduct weekly OPD consultations at Campal Clinic, St. Inez, Miramar in Panjim, and Royal Hospital, Aquem in Margao. This initiative aims to bring world-class cancer care closer to home, offering access to specialized treatments and leading oncologists for patients in Goa.
Patients will benefit from advanced treatments under the Mediclaim Goa Scheme, which covers a wide range of cutting-edge medical technologies, including robotic surgery, liver transplantation, CyberKnife, tomotherapy, bone marrow transplants (BMT), Ethos, and nuclear medicine (NMD). This government-supported scheme allows patients to receive care without upfront costs, alleviating financial burdens and reducing waiting times.
By offering these OPD consultations, HCG seeks to promote early cancer detection, increase awareness, and improve access to diverse treatment options in Goa. This initiative reflects HCG’s commitment to delivering swift and effective cancer care, focusing on patient-centric solutions that make high-quality treatment more accessible.
Ms. Manisha Kumar, Chief Operating Officer Karnataka, Healthcare Global Enterprises Limited said “At HCG, we are deeply committed to extending our specialized oncology services in Goa. Our highly skilled team of oncologists from HCG Cancer Centre Bangalore will provide comprehensive cancer care locally, ensuring that patients have immediate access to advanced treatment options and expert guidance without the need for extensive travel. This initiative reflects our dedication to enhancing patient care and improving health outcomes in the region. By integrating the latest advancements in cancer treatment into our services, we aim to deliver optimal care that meets the unique needs of each patient. We are excited about the positive impact this initiative will have on the lives of individuals and families affected by cancer in Goa.”
Dr. Raghunath SK, Senior consultant- Uro Oncology, HCG Cancer Centre Bangalore, said “Access to world-class cancer care is more critical than ever, especially with the rising incidence of cancer. Through our expanded presence in Goa, we are ensuring that patients no longer have to travel far to receive the highest standard of treatment. Since April 2024, HCG has been at the forefront of delivering advanced care in Goa, including robotic surgery, radiation therapy, interventional radiology, and ongoing chemotherapy. Our weekly OPD sessions provide patients with direct access to top oncologists in their own community, offering convenience and expertise in one place. At HCG, we are dedicated to early detection and swift intervention, which can significantly improve outcomes. We are proud to play a vital role in this initiative, bringing cutting-edge oncology care closer to those who need it most, right in their city.”
Dr. Natraj, Senior Consultant Hematology and BMT, HCG Cancer Centre Bangalore, remarked, “With an increase in cancer cases, it is imperative that we prioritize early detection and accessibility to quality treatment. Our presence in Goa allows us to address these critical needs head-on. By raising awareness and providing education on the importance of regular screenings, we can empower patients to seek help sooner. HCG is committed to ensuring that everyone in Goa has access to the most effective treatment options available, thereby improving survival rates and enhancing the overall health of the community.”
HCG Cancer Centre Bangalore is known for its advanced treatment methods, state-of-the-art diagnostic and treatment equipment, and outstanding patient results, delivering exemplary care to millions since its establishment. With cutting-edge technology for cancer diagnosis and treatment, including CyberKnife S7 nuclear medicine, PET-CT, genomics, and low-dose immunotherapy, the Centre prioritizes a patient-centric approach.
